Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

NEUROCRINE

  • FDA Approval
  • Dec. 14, 2024, 00:17 UTC
  • 50
  • 0 comments

FDA approve CRINECERFONT

Comment Full text

NEUROCRINE

  • FDA Approval
  • Dec. 13, 2024, 22:50 UTC
  • 63
  • 0 comments

FDA approve CRINECERFONT

Comment Full text

GALDERMA LABS LP

  • FDA Approval
  • Dec. 13, 2024, 20:37 UTC
  • 61
  • 0 comments

FDA approve NEMOLIZUMAB-ILTO

Comment Full text

DERMAVANT SCI

  • FDA Approval
  • Dec. 13, 2024, 19:13 UTC
  • 67
  • 0 comments

FDA approve TAPINAROF

Comment Full text

PFIZER

  • FDA Approval
  • Dec. 13, 2024, 19:13 UTC
  • 69
  • 0 comments

FDA approve RIMEGEPANT SULFATE

Comment Full text

APNAR PHARMA LP

  • FDA Approval
  • Dec. 13, 2024, 09:45 UTC
  • 61
  • 0 comments

FDA approve TERAZOSIN HYDROCHLORIDE

Comment Full text

MYLAN LABS LTD

  • FDA Approval
  • Dec. 13, 2024, 09:45 UTC
  • 59
  • 0 comments

FDA approve GLUCAGON

Comment Full text

ORBION PHARMS

  • FDA Approval
  • Dec. 13, 2024, 09:45 UTC
  • 61
  • 0 comments

FDA approve ARIPIPRAZOLE

Comment Full text

ALEMBIC

  • FDA Approval
  • Dec. 13, 2024, 09:45 UTC
  • 62
  • 0 comments

FDA approve ACETAZOLAMIDE

Comment Full text

FRESENIUS KABI USA

  • FDA Approval
  • Dec. 13, 2024, 09:45 UTC
  • 64
  • 0 comments

FDA approve CYTARABINE

Comment Full text
  • Previous
  • 232
  • 233
  • 234
  • 235
  • 236
  • Next

Search

News categories

  • Technical Exchange News(10600)
  • Event(2007)
  • SEC News(184713)
  • FDA Approval(9847)
  • Company Report(721)
  • Business News(122397)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin